Lushang Health Industry Development Co.,Ltd. (SHSE:600223) said it plans to sell assets and liabilities related to real estate business to company's controlling shareholder or affiliates.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.89 CNY | -5.96% | -3.07% | -18.07% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.07% | 1.11B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600223 Stock
- News Lushang Freda Pharmaceutical Co.,Ltd.
- Lushang Health Plans to Sell Real Estate Assets to Controlling Shareholder or Affiliates